GRemHAp

Hepatic Diseases in Primary Care Research Group

The Group of Hepatic Diseases in Primary Care belonging to the Metropolitan North USR of the Barcelona province was formed in 2005, being a group consolidated by IDIAP Jordi Gol and linked to the Center for Biomedical Research in the Network of Diseases Hepatic and Digestive (CIBEREHD). At the moment it is constituted by a stable group of researchers, made up of 7 doctors, a research technician, 4 nurses and a pharmacist. So far it has been characterized by the development of population studies in primary care. One of them included a total of 766 subjects being the basis of the first and only study on the prevalence of non-alcoholic fatty liver carried out in our country. Another study finalized recently with a total of 3076 subjects on the early detection of liver fibrosis in the general population. Study that has aroused much interest in the results obtained. We are currently tracking this cohort.

Group projects

PI: Caballería Rovira, Llorenç. Screening for liver fibrosis - population-based study across European countries. Funding: Fundació Clínic per a la Recerca Biomèdica. Duration: 2020 - 2024

PI: Caballería Rovira, Llorenç. Cribado poblacional de fibrosis hepática con elastografia transitoria en personas con factores de riesgo de enfermedad hepática e índice de grasa hepática elevado. Estudio de validación. Funding: Instituto de Salud Carlos III. Duration: 2019 - 2021

PI: Caballería Rovira, Llorenç. Algorithm for screening for liver fibrosis based on transient elastography in subjects with risk factors for liver disease and an increased fatty liver index. A validación study. Funding: Gilead Sciences, S.L.U. Duration: 2019 - 2020

PI: Caballería Rovira, Llorenç. Screening for liver fibrosis. A population-based study in European countries. The LiverScreen project. Funding: Gilead Sciences, S.L.U. Duration: 2018 - 2020

The group participates in the following projects

PI: Ribatallada Diez, Ana Maria. Estudi per avaluar la prevalença d'àcid úric en població sana i la seva relació amb la malaltia renal, la malaltia cardiovascular, el fetge gras no alcohòlic (FGNA ) i els factors de risc cardiovasculars clàssics. Funding: ICS - Institut Català de la Salut. Duration: 2020

The group participates in the following publications

Martínez Escudé A, Pera G, Arteaga I, Expósito C, Rodríguez L, Torán P, Caballeria L. Relationship between hypothyroidism and non-alcoholic fatty liver disease in the Spanish population. Med Clin (Barc). 2020 Jan; 154(1):1-6. doi:10.1016/j.medcli.2019.03.018. Epub 2019 May 29. PMID:31153607. IF: 1,635.

Rodríguez-Tajes S, Domínguez Á, Carrión JA, Buti M, Quer JC, Morillas RM, López C, Torras X, Baliellas C, Vergara M, Forner M, Zaragoza N, Salò J, Rigau J, Caballeria L, Mariño Z, Janè M, Colom J, Forns X, Lens S. Significant decrease in the prevalence of hepatitis C infection after the introduction of direct acting antivirals. J Gastroenterol Hepatol. 2020 Sep; 35(9):1570-1578. doi:10.1111/jgh.14984. Epub 2020 Feb 04. PMID:31957902. IF: 3,437.

Valerio L, Roure Díez S, Benítez R, Fernández-Rivas G, Rivaya B, Expósito C, Saperas C, Salvador F, Clotet B. [Intensified epidemiological surveillance of arbovirosis: First case of native dengue fever in Catalonia (Spain), Northern Metropolitan Area of Barcelona, 2018-2019]. Aten Primaria. 2021 01; 53(1):73-80. doi:10.1016/j.aprim.2020.07.002. Epub 2020 Oct 24. Spanish. pmc:PMC7752977. PMID:33342482. IF: 1,087.

Valerio L, Roure S, Expósito C, Saperas C, Benitez R, Rivaya E, Salvador F, Clotet B. Vigilancia epidemiológica intensificada de arbovirosis: primer caso de dengue autóctono en Cataluña (España), zona Metropolitana Norte de Barcelona, 2018-2019. Atención Primaria Basada en la Evidencia. 2020;53(1):73-80.

Indicators

Indicator

2020

Researchers with PhD

6

Total number of projects in which group members have participated

5

Total number of projects in which the PI of the project has belonged to the group

4

Total Funding

366.145 €

Scientific publications in indexed journals

3

Total Impact factor

6,16

Nº of articles in Q1 journals

0

Q1 IF

 

Nº of articles in Q2 journals

1

Q2 IF

3,437

Anar a l'inici